世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

注射用薬物送達デバイスの世界市場 2022-2026


Global Injectable Drug Delivery Devices Market 2022-2026

注射用薬物送達デバイスの世界市場 2022-2026 Technavioは注射用薬物送達デバイス市場を監視しており、2022年から2026年の間に222億9000万ドルの成長が見込まれ、予測期間中にCAGR8.48%で減速するとしています... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
TechNavio
テクナビオ
2022年2月1日 US$2,500
シングルユーザーライセンス
ライセンス・価格情報
注文方法はこちら
120 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

注射用薬物送達デバイスの世界市場 2022-2026
Technavioは注射用薬物送達デバイス市場を監視しており、2022年から2026年の間に222億9000万ドルの成長が見込まれ、予測期間中にCAGR8.48%で減速するとしています。当レポートでは、注射用薬物送達デバイス市場の全体分析、市場規模と予測、動向、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、慢性疾患の有病率の上昇と生物製剤市場の成長によって牽引されています。さらに、慢性疾患の有病率の上昇は、市場の成長をも押し上げると予想されます。
注射用薬物送達デバイスの市場分析には、タイプ別セグメントと地理的状況が含まれます。
Technavioの注射用薬物送達デバイス市場は、以下のようにセグメント化されています。
- タイプ別
- 先進的な注射用薬物送達デバイス
- 従来の注射用薬物送達デバイス
- 地域別
- 北米
- ヨーロッパ
- アジア
- 列
本調査では、医療システムのデジタル化が、今後数年間の注射用薬物送達デバイス市場の成長を促進する主要な理由の1つであると特定しています。
Technavioは、複数のソースからのデータの調査、合成、主要パラメータの分析による総括という方法で、市場の詳細なイメージを提示します。注射用薬物送達デバイス市場に関する当レポートは、以下の分野を対象としています。
- 注射用ドラッグデリバリーデバイスの市場規模
- 注射用薬物送達デバイスの市場予測
- 注射用薬物送達デバイス市場の産業分析
Technavioの強固なベンダー分析は、顧客が市場での地位を向上できるように設計されており、これに沿って本レポートでは、AstraZeneca Plc、Baxter International Inc、Becton Dickinson and Co、Eli Lilly and Co、Gerresheimer AG、Owen Mumford Ltd、Sanofi SA、 SCHOTT AG、 Teva Pharmaceutical Industries Ltd、Viatris Inc.など、注射薬送達デバイス市場の主要ベンダー数社の詳しい分析を掲載しています。また、注射用薬物送達デバイスの市場分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略的に活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報の客観的な組み合わせを使用して実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/injectable-drug-delivery-devices-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータを調査、合成、総括する方法で、市場の詳細なイメージを提示します。また、業界の主要な影響力を持つ人物を特定することで、市場の様々な側面を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る


目次

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2021
o Market outlook: Forecast for 2021 - 2026
• Five Forces Analysis
o Five Forces Summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Type
o Market segments
o Comparison by Type
o Advanced injectable drug delivery devices - Market size and forecast 2021-2026
o Conventional injectable drug delivery devices - Market size and forecast 2021-2026
o Market opportunity by Type
• Customer landscape
o Overview
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America - Market size and forecast 2021-2026
o Europe - Market size and forecast 2021-2026
o Asia - Market size and forecast 2021-2026
o ROW - Market size and forecast 2021-2026
o Key leading countries
o Market opportunity by geography
• Drivers, Challenges, and Trends
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Landscape disruption
o Competitive landscape
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o AstraZeneca Plc
o Baxter International Inc.
o Becton Dickinson and Co.
o Eli Lilly and Co.
o Gerresheimer AG
o Owen Mumford Ltd.
o Sanofi SA
o SCHOTT AG
o Teva Pharmaceutical Industries Ltd.
o Viatris Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research Methodology
o List of abbreviations

Exhibits
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global - Market size and forecast 2021 - 2026 ($ million)
• 13: Global market: Year-over-year growth 2021 - 2026 (%)
• 14: Five forces analysis 2021 & 2026
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition - Five forces 2021
• 21: Type - Market share 2021-2026 (%)
• 22: Comparison by Type
• 23: Advanced injectable drug delivery devices - Market size and forecast 2021-2026 ($ million)
• 24: Advanced injectable drug delivery devices - Year-over-year growth 2021-2026 (%)
• 25: Conventional injectable drug delivery devices - Market size and forecast 2021-2026 ($ million)
• 26: Conventional injectable drug delivery devices - Year-over-year growth 2021-2026 (%)
• 27: Market opportunity by Type
• 28: Customer landscape
• 29: Market share by geography 2021-2026 (%)
• 30: Geographic comparison
• 31: North America - Market size and forecast 2021-2026 ($ million)
• 32: North America - Year-over-year growth 2021-2026 (%)
• 33: Europe - Market size and forecast 2021-2026 ($ million)
• 34: Europe - Year-over-year growth 2021-2026 (%)
• 35: Asia - Market size and forecast 2021-2026 ($ million)
• 36: Asia - Year-over-year growth 2021-2026 (%)
• 37: ROW - Market size and forecast 2021-2026 ($ million)
• 38: ROW - Year-over-year growth 2021-2026 (%)
• 39: Key leading countries
• 40: Market opportunity by geography ($ million)
• 41: Impact of drivers and challenges
• 42: Vendor landscape
• 43: Landscape disruption
• 44: Industry risks
• 45: Vendors covered
• 46: Market positioning of vendors
• 47: AstraZeneca Plc - Overview
• 48: AstraZeneca Plc - Product and service
• 49: AstraZeneca Plc - Key offerings
• 50: AstraZeneca Plc - Key customers
• 51: AstraZeneca Plc - Segment focus
• 52: Baxter International Inc. - Overview
• 53: Baxter International Inc. - Business segments
• 54: Baxter International Inc. - Key offerings
• 55: Baxter International Inc. - Key customers
• 56: Baxter International Inc. - Segment focus
• 57: Becton Dickinson and Co. - Overview
• 58: Becton Dickinson and Co. - Business segments
• 59: Becton Dickinson and Co. - Key offerings
• 60: Becton Dickinson and Co. - Key customers
• 61: Becton Dickinson and Co. - Segment focus
• 62: Eli Lilly and Co. - Overview
• 63: Eli Lilly and Co. - Business segments
• 64: Eli Lilly and Co. - Key offerings
• 65: Eli Lilly and Co. - Key customers
• 66: Eli Lilly and Co. - Segment focus
• 67: Gerresheimer AG - Overview
• 68: Gerresheimer AG - Business segments
• 69: Gerresheimer AG - Key offerings
• 70: Gerresheimer AG - Key customers
• 71: Gerresheimer AG - Segment focus
• 72: Owen Mumford Ltd. - Overview
• 73: Owen Mumford Ltd. - Product and service
• 74: Owen Mumford Ltd. - Key offerings
• 75: Owen Mumford Ltd. - Key customers
• 76: Owen Mumford Ltd. - Segment focus
• 77: Sanofi SA - Overview
• 78: Sanofi SA - Business segments
• 79: Sanofi SA - Key offerings
• 80: Sanofi SA - Key customers
• 81: Sanofi SA - Segment focus
• 82: SCHOTT AG - Overview
• 83: SCHOTT AG - Business segments
• 84: SCHOTT AG - Key offerings
• 85: SCHOTT AG - Key customers
• 86: SCHOTT AG - Segment focus
• 87: Teva Pharmaceutical Industries Ltd. - Overview
• 88: Teva Pharmaceutical Industries Ltd. - Business segments
• 89: Teva Pharmaceutical Industries Ltd. - Key offerings
• 90: Teva Pharmaceutical Industries Ltd. - Key customers
• 91: Teva Pharmaceutical Industries Ltd. - Segment focus
• 92: Viatris Inc. - Overview
• 93: Viatris Inc. - Business segments
• 94: Viatris Inc. - Key offerings
• 95: Viatris Inc. - Key customers
• 96: Viatris Inc. - Segment focus
• 97: Currency conversion rates for US$
• 98: Research Methodology
• 99: Validation techniques employed for market sizing
• 100: Information sources
• 101: List of abbreviations

 

ページTOPに戻る


 

Summary

Global Injectable Drug Delivery Devices Market 2022-2026
Technavio has been monitoring the injectable drug delivery devices market and it is poised to grow by $ 22.29 bn during 2022-2026, decelerating at a CAGR of 8.48% during the forecast period. Our report on the injectable drug delivery devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of chronic diseases and growth in the biologics market. In addition, the rising prevalence of chronic diseases is anticipated to boost the growth of the market as well.
The injectable drug delivery devices market analysis includes the type segment and geographic landscape.
Technavio's injectable drug delivery devices market is segmented as below:
• By Type
• Advanced injectable drug delivery devices
• Conventional injectable drug delivery devices
• By Geography
• North America
• Europe
• Asia
• ROW
This study identifies digitalization in the healthcare system as one of the prime reasons driving the injectable drug delivery devices market growth during the next few years.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on injectable drug delivery devices market covers the following areas:
• Injectable drug delivery devices market sizing
• Injectable drug delivery devices market forecast
• Injectable drug delivery devices market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading injectable drug delivery devices market vendors that include AstraZeneca Plc, Baxter International Inc., Becton Dickinson and Co., Eli Lilly and Co., Gerresheimer AG, Owen Mumford Ltd., Sanofi SA, SCHOTT AG, Teva Pharmaceutical Industries Ltd., and Viatris Inc. Also, the injectable drug delivery devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/injectable-drug-delivery-devices-market-industry-analysis
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.



ページTOPに戻る


Table of Contents

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2021
o Market outlook: Forecast for 2021 - 2026
• Five Forces Analysis
o Five Forces Summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Type
o Market segments
o Comparison by Type
o Advanced injectable drug delivery devices - Market size and forecast 2021-2026
o Conventional injectable drug delivery devices - Market size and forecast 2021-2026
o Market opportunity by Type
• Customer landscape
o Overview
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America - Market size and forecast 2021-2026
o Europe - Market size and forecast 2021-2026
o Asia - Market size and forecast 2021-2026
o ROW - Market size and forecast 2021-2026
o Key leading countries
o Market opportunity by geography
• Drivers, Challenges, and Trends
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Landscape disruption
o Competitive landscape
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o AstraZeneca Plc
o Baxter International Inc.
o Becton Dickinson and Co.
o Eli Lilly and Co.
o Gerresheimer AG
o Owen Mumford Ltd.
o Sanofi SA
o SCHOTT AG
o Teva Pharmaceutical Industries Ltd.
o Viatris Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research Methodology
o List of abbreviations

Exhibits
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global - Market size and forecast 2021 - 2026 ($ million)
• 13: Global market: Year-over-year growth 2021 - 2026 (%)
• 14: Five forces analysis 2021 & 2026
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition - Five forces 2021
• 21: Type - Market share 2021-2026 (%)
• 22: Comparison by Type
• 23: Advanced injectable drug delivery devices - Market size and forecast 2021-2026 ($ million)
• 24: Advanced injectable drug delivery devices - Year-over-year growth 2021-2026 (%)
• 25: Conventional injectable drug delivery devices - Market size and forecast 2021-2026 ($ million)
• 26: Conventional injectable drug delivery devices - Year-over-year growth 2021-2026 (%)
• 27: Market opportunity by Type
• 28: Customer landscape
• 29: Market share by geography 2021-2026 (%)
• 30: Geographic comparison
• 31: North America - Market size and forecast 2021-2026 ($ million)
• 32: North America - Year-over-year growth 2021-2026 (%)
• 33: Europe - Market size and forecast 2021-2026 ($ million)
• 34: Europe - Year-over-year growth 2021-2026 (%)
• 35: Asia - Market size and forecast 2021-2026 ($ million)
• 36: Asia - Year-over-year growth 2021-2026 (%)
• 37: ROW - Market size and forecast 2021-2026 ($ million)
• 38: ROW - Year-over-year growth 2021-2026 (%)
• 39: Key leading countries
• 40: Market opportunity by geography ($ million)
• 41: Impact of drivers and challenges
• 42: Vendor landscape
• 43: Landscape disruption
• 44: Industry risks
• 45: Vendors covered
• 46: Market positioning of vendors
• 47: AstraZeneca Plc - Overview
• 48: AstraZeneca Plc - Product and service
• 49: AstraZeneca Plc - Key offerings
• 50: AstraZeneca Plc - Key customers
• 51: AstraZeneca Plc - Segment focus
• 52: Baxter International Inc. - Overview
• 53: Baxter International Inc. - Business segments
• 54: Baxter International Inc. - Key offerings
• 55: Baxter International Inc. - Key customers
• 56: Baxter International Inc. - Segment focus
• 57: Becton Dickinson and Co. - Overview
• 58: Becton Dickinson and Co. - Business segments
• 59: Becton Dickinson and Co. - Key offerings
• 60: Becton Dickinson and Co. - Key customers
• 61: Becton Dickinson and Co. - Segment focus
• 62: Eli Lilly and Co. - Overview
• 63: Eli Lilly and Co. - Business segments
• 64: Eli Lilly and Co. - Key offerings
• 65: Eli Lilly and Co. - Key customers
• 66: Eli Lilly and Co. - Segment focus
• 67: Gerresheimer AG - Overview
• 68: Gerresheimer AG - Business segments
• 69: Gerresheimer AG - Key offerings
• 70: Gerresheimer AG - Key customers
• 71: Gerresheimer AG - Segment focus
• 72: Owen Mumford Ltd. - Overview
• 73: Owen Mumford Ltd. - Product and service
• 74: Owen Mumford Ltd. - Key offerings
• 75: Owen Mumford Ltd. - Key customers
• 76: Owen Mumford Ltd. - Segment focus
• 77: Sanofi SA - Overview
• 78: Sanofi SA - Business segments
• 79: Sanofi SA - Key offerings
• 80: Sanofi SA - Key customers
• 81: Sanofi SA - Segment focus
• 82: SCHOTT AG - Overview
• 83: SCHOTT AG - Business segments
• 84: SCHOTT AG - Key offerings
• 85: SCHOTT AG - Key customers
• 86: SCHOTT AG - Segment focus
• 87: Teva Pharmaceutical Industries Ltd. - Overview
• 88: Teva Pharmaceutical Industries Ltd. - Business segments
• 89: Teva Pharmaceutical Industries Ltd. - Key offerings
• 90: Teva Pharmaceutical Industries Ltd. - Key customers
• 91: Teva Pharmaceutical Industries Ltd. - Segment focus
• 92: Viatris Inc. - Overview
• 93: Viatris Inc. - Business segments
• 94: Viatris Inc. - Key offerings
• 95: Viatris Inc. - Key customers
• 96: Viatris Inc. - Segment focus
• 97: Currency conversion rates for US$
• 98: Research Methodology
• 99: Validation techniques employed for market sizing
• 100: Information sources
• 101: List of abbreviations

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(電子部品/半導体)の最新刊レポート


よくあるご質問


TechNavio社はどのような調査会社ですか?


テクナビオ(TechNavio)は英国ロンドンに本社をおく幅広い市場を調査対象とする調査会社インフィニティリサーチ社(Infiniti Research)の調査レポート出版部門です。データリソースはT... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/21 10:26

156.13 円

165.08 円

200.38 円

ページTOPに戻る